Annual Retained Earnings
-$90.06 M
-$42.19 M-88.14%
31 December 2023
Summary:
SAB Biotherapeutics annual retained earnings is currently -$90.06 million, with the most recent change of -$42.19 million (-88.14%) on 31 December 2023. During the last 3 years, it has fallen by -$78.08 million (-651.51%). SABS annual retained earnings is now -651.51% below its all-time high of -$11.98 million, reached on 31 December 2020.SABS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$112.77 M
-$10.35 M-10.10%
30 September 2024
Summary:
SAB Biotherapeutics quarterly retained earnings is currently -$112.77 million, with the most recent change of -$10.35 million (-10.10%) on 30 September 2024. Over the past year, it has dropped by -$45.57 million (-67.80%). SABS quarterly retained earnings is now -1113.45% below its all-time high of -$9.29 million, reached on 30 September 2021.SABS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -88.1% | -67.8% |
| 3 y3 years | -651.5% | -1113.5% |
| 5 y5 years | - | - |
SABS Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -651.5% | at low | -1113.5% | at low |
| 5 y | 5 years | -651.5% | at low | -1113.5% | at low |
| alltime | all time | -651.5% | at low | -1113.5% | at low |
SAB Biotherapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$112.77 M(+10.1%) |
| June 2024 | - | -$102.42 M(+7.7%) |
| Mar 2024 | - | -$95.09 M(+5.6%) |
| Dec 2023 | -$90.06 M(+88.1%) | -$90.06 M(+34.0%) |
| Sept 2023 | - | -$67.21 M(+8.2%) |
| June 2023 | - | -$62.10 M(+12.5%) |
| Mar 2023 | - | -$55.22 M(+15.4%) |
| Dec 2022 | -$47.87 M | -$47.87 M(+19.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$40.00 M(+21.5%) |
| June 2022 | - | -$32.92 M(+17.0%) |
| Mar 2022 | - | -$28.14 M(-3.4%) |
| Dec 2021 | -$29.13 M(+143.1%) | -$29.13 M(+213.4%) |
| Sept 2021 | - | -$9.29 M(-31.2%) |
| June 2021 | - | -$13.52 M(+12.8%) |
| Dec 2020 | -$11.98 M(-62.7%) | -$11.98 M |
| Dec 2019 | -$32.10 M | - |
FAQ
- What is SAB Biotherapeutics annual retained earnings?
- What is the all time high annual retained earnings for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual retained earnings year-on-year change?
- What is SAB Biotherapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly retained earnings year-on-year change?
What is SAB Biotherapeutics annual retained earnings?
The current annual retained earnings of SABS is -$90.06 M
What is the all time high annual retained earnings for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual retained earnings is -$11.98 M
What is SAB Biotherapeutics annual retained earnings year-on-year change?
Over the past year, SABS annual retained earnings has changed by -$42.19 M (-88.14%)
What is SAB Biotherapeutics quarterly retained earnings?
The current quarterly retained earnings of SABS is -$112.77 M
What is the all time high quarterly retained earnings for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly retained earnings is -$9.29 M
What is SAB Biotherapeutics quarterly retained earnings year-on-year change?
Over the past year, SABS quarterly retained earnings has changed by -$45.57 M (-67.80%)